Selection of induction therapy in kidney transplantation
about
Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study.Near-term anti-CD25 monoclonal antibody administration protects murine liver from ischemia-reperfusion injury due to reduced numbers of CD4+ T cellsInduction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid MaintenanceA Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology.Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression.Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients.Unintended Immunological Consequences of Biologic Therapy.Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.Profiling risk for acute rejection in kidney transplantation: recipient age is a robust risk factor.Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States.[Immunosuppression and its use in kidney transplantation].Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and MycophenolateRapidly growing non-tuberculous mycobacterial infection in a renal transplant patient after alemtuzumab induction.Analysis of Risk Factors for Kidney Retransplant Outcomes Associated with Common Induction Regimens: A Study of over Twelve-Thousand Cases in the United States.Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation.Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation.
P2860
Q34027642-029E353A-D6A0-4150-8AD0-5AEA0F32DDEBQ34134224-41395C9A-EDC0-4430-85A6-6FA0437121F9Q35682221-3E161F80-B048-425C-8FC8-50AEDD277C5AQ35805955-E925F63B-E51F-4771-8A90-1895C8BEE207Q37745268-83D7E7B7-6622-42B2-929D-3C93DD67DACEQ38706959-117DE3D8-1966-4C7E-BE1F-80F64680C47DQ38802439-3D0A9FEF-E97B-4FE6-B0DC-C27F08676D36Q38871098-FDD377D0-A458-4F86-A354-9386786D3823Q38892578-7113360B-0576-4AC9-BE62-E624AAA8CB2EQ39338311-98EC9CA6-69F0-4928-B45A-45D253C188A4Q39630797-ED085B9C-1485-493B-A7E4-FFC2C7318F3EQ40956126-6E6466EB-4BAF-41EE-9AEB-CFB818904B8CQ41022599-E8E8FCCC-DADA-4B59-A9C5-CF348BE1BE70Q42205422-4ECC83BF-88AE-4B8D-8519-B45381346256Q47193453-1E9BF9ED-3F60-4DA5-B9C8-E0886A1A0B82Q49724077-40B41E45-238E-46B3-B457-1808B3A8CEE6Q50781725-8F2CCFAB-3C7F-465A-9C7C-186E2BC5E1DB
P2860
Selection of induction therapy in kidney transplantation
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Selection of induction therapy in kidney transplantation
@ast
Selection of induction therapy in kidney transplantation
@en
Selection of induction therapy in kidney transplantation
@nl
type
label
Selection of induction therapy in kidney transplantation
@ast
Selection of induction therapy in kidney transplantation
@en
Selection of induction therapy in kidney transplantation
@nl
prefLabel
Selection of induction therapy in kidney transplantation
@ast
Selection of induction therapy in kidney transplantation
@en
Selection of induction therapy in kidney transplantation
@nl
P2093
P2860
P356
P1476
Selection of induction therapy in kidney transplantation
@en
P2093
Christina L. Klein
Daniel C. Brennan
Karen L. Hardinger
P2860
P304
P356
10.1111/TRI.12043
P407
P577
2013-07-01T00:00:00Z